Glenmark Pharmaceuticals Share Price
₹1,585.95 +44.5 (2.89%)
28 Dec, 2024 02:32
Start SIP in GLENMARK
Start SIPPerformance
- Low
- ₹1,540
- High
- ₹1,605
- 52 Week Low
- ₹771
- 52 Week High
- ₹1,831
- Open Price₹1,541
- Previous Close₹1,541
- Volume1,282,686
Investment Returns
- Over 1 Month + 4.24%
- Over 3 Month -5.5%
- Over 6 Month + 29.32%
- Over 1 Year + 87.92%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -51.1
- PEG Ratio
- 0.1
- Market Cap Cr
- 44,754
- P/B Ratio
- 5.7
- Average True Range
- 45.98
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- -15.54
- RSI
- 56.68
- MFI
- 52.34
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,585.95
+
44.5
(2.89%)
- Bullish Moving Average 14
- Bearish Moving Average 2
- 20 Day
- ₹1,545.66
- 50 Day
- ₹1,572.62
- 100 Day
- ₹1,546.62
- 200 Day
- ₹1,403.45
Resistance and Support
1576.88
- R3 1,677.87
- R2 1,641.18
- R1 1,613.57
- S1 1,549.27
- S2 1,512.58
- S3 1,484.97
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results | |
2023-11-10 | Quarterly Results |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,585 As on 28 December, 2024 | 02:18
The Market Cap of Glenmark Pharmaceuticals is ₹44753.6 Cr As on 28 December, 2024 | 02:18
The P/E ratio of Glenmark Pharmaceuticals is -51.1 As on 28 December, 2024 | 02:18
The PB ratio of Glenmark Pharmaceuticals is 5.7 As on 28 December, 2024 | 02:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.